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http://dx.doi.org/10.1016/j.kjms.201Abstract This study was a double-blinded randomized control trial designed to investigate
the hemodynamic effects of dexmedetomidine on prolonged tourniquet inflation. Thirty-
seven patients scheduled for elective orthopedic surgery of the lower limb under general anes-
thesia were recruited. They were randomly assigned to receive intravenous dexmedetomidine
(DEX, 0.5 mg/kg; n Z 18) or normal saline (CON; n Z 19) before tourniquet inflation. Arterial
blood pressure and heart rate were recorded every 10 minutes until 60 minutes after the start
of tourniquet inflation and again immediately after deflation. In the DEX group, arterial pres-
sure was not significantly changed, but in the CON group arterial pressure was significantly
increased at 40, 50, and 60 minutes after the start of tourniquet inflation. Development of
more than 30% increase in arterial pressure during tourniquet inflation was more frequent in
the CON group than in the DEX group. Preoperative intravenous dexmedetomidine could there-
fore prevent tourniquet-induced hypertension in patients undergoing general anesthesia.
Copyright ª 2012, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Tourniquets are widely used in orthopedic surgery of the
extremities to reduce surgical bleeding, but prolongedt of Anesthesiology, Second
l University, Hefei 230601,
ina.com (Y. Zhang).
hsiung Medical University. Publish
2.09.006inflation is also associated with severe pain which, in turn,
is often accompanied by a progressive increase in systemic
arterial pressure [1,2]. Tourniquet-induced hypertension
(TIH) is generally defined as a progressive increase of more
than 30% in arterial blood pressure after tourniquet infla-
tion under general anesthesia [3,4]. The onset of TIH is
delayed, and its treatment is difficult and often ineffective,
even with increased doses of anesthetics and antihyper-
tensive drugs [4]. Clonidine [5], ketamine [6], magnesiumed by Elsevier Taiwan LLC. All rights reserved.
Table 1 Demographic data, dose of propofol and remi-





Age (y) 37  11 40  12
Sex (m/f) 11/8 12/6
Height (cm) 173  5 170  7
Weight (kg) 70  8 67  11
Tourniquet (min) 67  6 69  7
Propofol dose (mg) 407  49 387  32
Remifentanil dose (mg) 1062  288 983  168
Duration of anesthesia (min) 96  18 104  18
Values are presented as mean  SD. There were no significant
differences between groups.
CON Z group receiving normal saline; DEX Z group receiving
dexmedetomidine; Tourniquet Z duration of tourniquet
inflation.
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prophylactically to prevent TIH. Although the mechanism of
TIH is unknown, the autonomic nervous system is involved
[1]. Dexmedetomidine is a potent a2-adrenoceptor agonist
with eight times higher affinity for the a2-adrenoceptor than
clonidine,and ithas shownsedative,analgesic, andanxiolytic
effects after intravenous administration [9]. Dexmedetomi-
dine attenuates hyperadrenergic responses and therefore
may be of therapeutic or prophylactic value for TIH.
In this study, we investigated the effect of preoperative
intravenous dexmedetomidine on arterial blood pressure
and heart rate in patients undergoing general anesthesia
for orthopedic surgery of the lower limbs with a tourniquet.
Methods
This study was randomized, double-blinded, and placebo-
controlled. After approval was obtained from the ethics
committee of the Third Affiliated Hospital of Anhui Medical
University and written informed consent was received from
each patient, 37 ASA (American Society of Anesthesiologists)
physical status class I and II patients scheduled for ortho-
pedic operation requiring tourniquet inflation of the lower
limbs under general anesthesia were enrolled. Patients with
known contraindications to dexmedetomidine; who had
ischemic heart disease, hypertension, kidney dysfunction, or
diabetes mellitus; and with expected tourniquet inflation
time shorter than 60 minutes were excluded.
All patients received intramuscular phenobarbital
(0.5 mg) 30 minutes before induction of anesthesia.
Patients in the dexmedetomidine group (DEX; n Z 18)
received intravenous dexmedetomidine (0.5 mg/kg) diluted
in 10 mL normal saline infused over 10 minutes, immedi-
ately before induction of anesthesia. Patients in the control
group (CON; n Z 19) received the same volume of normal
saline infused over the same period. The infusions were
prepared by a nurse anesthetist not involved with the case
according to a computer-generated sequence. Anesthesia
was induced with fentanyl (2e4 mg/kg) and propofol (2 mg/
kg), and vecuronium (0.1 mg/kg) was given intravenously to
facilitate intubation of the trachea. Arterial pressure
before induction of anesthesia was measured noninvasively.
After anesthesia induction, a radial artery catheter was
inserted for invasive blood pressure measurements. Anes-
thesia was maintained with propofol (75 mg/kg/min) and
remifentanil (0.1 mg/kg/min). Muscle paralysis was main-
tained with vecuronium. Tidal volume was adjusted to keep
the end-tidal CO2 concentration 35e45 mmHg. After skin
incision, the tourniquet was inflated to a pressure of
300 mmHg. If systolic arterial pressure exceeded 180 mmHg
despite increased doses of propofol and remifentanil, an
additional bolus of nitroglycerol was given intravenously.
Blood pressure and heart rate were recorded at 0, 10,
20, 30, 40, 50, and 60 minutes after the start of tourniquet
inflation and immediately after tourniquet deflation. The
number of patients who developed TIH, as defined by an
increase in arterial blood pressure greater than 30% of the
baseline value, was recorded. The patients were extubated
at the end of surgery after reversal with atropine (0.5 mg)
and neostigmine (1 mg).
Statistical analysis was performed using the SPSS 10.0
program (SPSS Inc., Chicago, IL, USA). All data are presentedas mean  standard deviation. Demographic data for the
patients were compared among the groups using one-way
analysis of variance with the post hoc Scheffe´ test. The
hemodynamic changes were compared with the baseline
values and among the groups by using two-way repeated-
measures analysis of variancewith Tukey’s post hoc test. The
c2 testwas used to compare the number of patientswith TIH.
Statistical differences were considered significant if the
p value was less than 0.05.
Results
There were no statistically significant differences between
the groups with respect to the patients’ demographic
characteristics, dose of propofol and remifentanil, time for
duration of tourniquet inflation, and anesthesia (Table 1).
In the DEX group, systolic and diastolic arterial pressures
were not changed during the study period, but in the CON
group, systolic arterial pressure and diastolic arterial
pressure were significantly increased at 40, 50, and 60
minutes after the start of tourniquet inflation. In all
patients, the heart rate did not change significantly during
tourniquet inflation, but there was a significant increase
immediately after deflation in the CON group (Fig. 1). The
CON group had a greater percentage of patients who
developed TIH when compared with the DEX group.
Discussion
The results from this study showed that preoperative
intravenous dexmedetomidine significantly prevented
a systemic arterial pressure increase during prolonged
tourniquet inflation in patients under general anesthesia.
Perioperative hypertension may be associated with
serious cardiac complications [10e12]. Furthermore, the
level of hypertension is correlated with the occurrence of
postoperative silent myocardial ischemia [12]. The intra-
operative hypertension induced by prolonged tourniquet
inflation of the lower limbs is often unresponsive to
increased doses of anesthetics and antihypertensive drugs
Figure 1. Hemodynamic changes in the two groups. Values
are presented as mean  SD. After Z immediately after
tourniquet deflation; Baseline Z immediately before anes-
thesia induction; Before Z after anesthesia induction and
immediately before tourniquet inflation; CON Z group
receiving normal saline; DBP Z diastolic blood pressure;
DEX Z dexmedetomidine; HR Z heart rate; SBP Z systolic
blood pressure.
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develops, it is often difficult to control. In these patients,
intravenous dexmedetomidine before tourniquet inflation
may have a role in attenuating these blood pressure
increases. Tetzlaff et al. [1] showed that tourniquet-
induced arterial pressure increases correlate with the
activation of the sympathetic nervous system, as measured
by power spectral heart rate analysis. An increase in plasma
norepinephrine levels was related to the tourniquet-induced arterial pressure increase under general anes-
thesia [13]. Catecholamine release after the activation of
the sympathetic nervous system may contribute to the
increase in systemic arterial pressure during prolonged
tourniquet inflation. Dexmedetomidine is an a2-receptor
agonist with both sedative and analgesic properties that
reduce the sedation, anxiolytic, and analgesic require-
ments in the perioperative setting [9]. Dexmedetomidine
improves hemodynamic stability in the perioperative period
by exerting sympatholytic effects via activation of the
inhibitory a2-receptors both in the central nervous system
and on peripheral sympathetic nerve endings [14,15], and
reduces plasma epinephrine and norepinephrine levels
[16,17]. Dexmedetomidine has been reported to be useful
in attenuating hemodynamic stress secondary to hyper-
adrenergic over-reactivity [18].
In awake patients, the addition of dexmedetomidine to
the local anesthetic solution in intravenous regional anes-
thesia decreases tourniquet pain [19]. Preoperative intra-
venous clonidine blunts both the increase in sympathetic
out flow and arterial hypertension associated with tourni-
quet inflation under general anesthesia [5]. In this study,
we have shown that preoperative intravenous dexmedeto-
midine could also prevent TIH. The use of dexmedetomi-
dine may have added benefits such as attenuating the
cardiovascular and sympathoadrenal response to intubation
and extubation [20] and reducing opioid requirements
during and after surgery [20,21]. Dexmedetomidine
decreases the incidence and frequency of delirium in chil-
dren [22] and adults [23].
There are several limitations in this study. First, we did
not perform a doseeresponse study having only used one
dose. Future studies could evaluate whether smaller doses
can achieve the same benefit or whether larger doses can
reduce TIH to a greater extent. Second, the effect of
dexmedetomidine on the relationship between tourniquet-
induced pain and hypertension was not evaluated, because
this study was performed in patients receiving general
anesthesia. Lastly, the depth of anesthesia might have been
different in the two groups as we did not use any depth of
anesthesia monitoring However, there were no significant
differences in propofol and remifentanil consumption
during the study period and arterial pressure before tour-
niquet inflation between the groups.
In conclusion, preoperative intravenous dexmedetomi-
dine significantly prevents hemodynamic responses to pro-
longed tourniquet inflation of the lower limbs under general
anesthesia in patients. On the basis of the results of this
study, further investigations are needed to show whether
perioperative outcome in patients with arterial hyperten-
sion or cardiovascular disease is improved by dexmedeto-
midine treatment.
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